13299-58-6

Upstream product

• 1240971-20-3 3-methyl-4-trifluoromethanesulfonyloxy-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 34737-89-8 1-Benzyl-3-methyl-4-piperidon 
• 181269-69-2 tert-butyl 3-methyl-4-oxopiperidine-1-carboxylate 
• 923949-12-6 tert-butyl 3-methyl-4-phenyl-3,6-dihydropyridine-1(2H)-carboxylate 
• 13299-63-3 1-benzyl-3-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine 

Downstream Products

• 923949-12-6 tert-butyl 3-methyl-4-phenyl-3,6-dihydropyridine-1(2H)-carboxylate 

Relevant academic research and scientific papers

NEW ANTIBACTERIAL COMPOUNDS

The present invention is related to novel compounds of formula (I) that may inhibit the activity of the FabI enzyme, and which are useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compound

ANTIBACTERIAL PIPERIDINYL SUBSTITUTED 3,4-DIHYDRO-1H-[1,8]NAPHTHYRIDINONES

The present invention is related to novel compounds of formula (I) that inhibit the activity of the Fab1 enzyme which are therefore useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.

PIPERIDINOYL-PYRROLIDINE AND PIPERIDINOYL-PIPERIDINE COMPOUNDS

The present invention relates to a class of compounds of general formula (I) and the salts, hydrates, solvates, polymorphs and prodrugs wherein n, R6, R7 and R10 are as defined herein and especially to MCR4 agonist compounds of formula (I), to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.